Dr Sandar Tin Tin
Sandar Tin Tin
MBBS, MPH, PhD
Girdlers’ New Zealand HRC Fellow
Sandar joined the Cancer Epidemiology Unit as a Girdlers’ New Zealand HRC (Health Research Council) Fellow in August 2019. She was trained as a medical doctor in Myanmar and holds a Master of Public Health and a PhD from the University of Auckland, New Zealand.
Sandar has a broad interest in the theoretical, methodological and applied aspects of epidemiological research, and has undertaken a number of research projects related to cancer, active travel, injury and child and youth health. Her current research is based on the UK Biobank and examines physical activity, biomarkers and breast cancer risk.
Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.
Bartholomew K. et al, (2023), BMC Cancer, 23
A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S. et al, (2023), BMC Cancer, 23
Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.
Win Myint TT. et al, (2023), Cancer Epidemiol, 85
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
Scott OW. et al, (2023), Breast Cancer Research and Treatment, 199, 195 - 206
Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.
Mahamat-Saleh Y. et al, (2023), Cancer Med